product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Phospho-FGF Receptor (Tyr653/654) (55H2) Mouse mAb
catalog :
3476S
quantity :
100 ul
price :
274 USD
clonality :
monoclonal
host :
mouse
antigen modification :
phosphorylated
reactivity :
human, mouse, rat
application :
western blot
citations: 3
Published Application/Species/DilutionReference
  • western blot; human
Wang J, Mikse O, Liao R, Li Y, Tan L, Jänne P, et al. Ligand-associated ERBB2/3 activation confers acquired resistance to FGFR inhibition in FGFR3-dependent cancer cells. Oncogene. 2015;34:2167-77 pubmed publisher
Borroto-Escuela D, Romero-Fernandez W, Pérez-Alea M, Narvaez M, Tarakanov A, Mudo G, et al. The existence of FGFR1-5-HT1A receptor heterocomplexes in midbrain 5-HT neurons of the rat: relevance for neuroplasticity. J Neurosci. 2012;32:6295-303 pubmed publisher
Kentsis A, Reed C, Rice K, Sanda T, Rodig S, Tholouli E, et al. Autocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemia. Nat Med. 2012;18:1118-22 pubmed publisher
product information
SKU :
3476S
Product-Name :
Phospho-FGF Receptor (Tyr653/654) (55H2) Mouse mAb
Size :
100 ul
Price-(USD) :
274 USD
Species-x-Reactivity :
H, (M, R)
Applications :
Western blot
Product-Category :
RTK
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Monoclonal Antibody
MW :
120, 145
Host :
Mouse
Target :
FGFR1 (Tyr653/Tyr654) phosphate
Primary-Protein :
FGFR1
Alt-Names :
BFGFR,Basic fibroblast growth factor receptor 1,CD331,CEK,FGFBR,FGFR-1,FGFR1,FLG,FLJ99988,FLT-2,FLT2,Fms-like tyrosine kinase 2,HBGFR,KAL2,N-SAM,OGD,Proto-oncogene c-Fgr,bFGF-R-1,fibroblast growth factor receptor 1,fms-related tyrosine kinase 2,heparin-binding growth factor receptor,hydroxyaryl-protein kinase,soluble FGFR1 variant 1,soluble FGFR1 variant 2
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.